Corcept Therapeutics
Development of cortisol blockers
- B2B
About Corcept Therapeutics
Leading the research and development of cortisol modulation for treating serious diseases through innovative glucocorticoid receptor antagonists and groundbreaking treatments
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Redwood City, California, United States
- Founded
- 1998
- Revenue
- $761MFY2025, publicly reported
- Website
- corcept.com
Corcept Therapeutics at a glance
Corcept Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Redwood City, California, United States.
Corcept Therapeutics was founded in 1998.
Corcept Therapeutics has 251–1,000 employees.
Corcept Therapeutics's revenue is $761M (FY2025, publicly reported).
Selling to companies like Corcept Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies